- Home
- HL vs ACLX Comparison
HL vs ACLX Comparison
Compare HL & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HL
- ACLX
- Stock Information
- Founded
- HL 1891
- ACLX 2015
- Country
- HL United States
- ACLX United States
- Employees
- HL N/A
- ACLX N/A
- Industry
- HL Precious Metals
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- HL Basic Materials
- ACLX Health Care
- Exchange
- HL Nasdaq
- ACLX Nasdaq
- Market Cap
- HL 9.9B
- ACLX 4.4B
- IPO Year
- HL N/A
- ACLX 2022
- Fundamental
- Price
- HL $14.74
- ACLX $90.01
- Analyst Decision
- HL Buy
- ACLX Strong Buy
- Analyst Count
- HL 7
- ACLX 8
- Target Price
- HL $10.93
- ACLX $115.50
- AVG Volume (30 Days)
- HL 17.8M
- ACLX 427.8K
- Earning Date
- HL 11-05-2025
- ACLX 11-05-2025
- Dividend Yield
- HL 0.10%
- ACLX N/A
- EPS Growth
- HL N/A
- ACLX N/A
- EPS
- HL 0.31
- ACLX N/A
- Revenue
- HL $1,224,563,000.00
- ACLX $35,898,000.00
- Revenue This Year
- HL $16.78
- ACLX N/A
- Revenue Next Year
- HL $2.30
- ACLX $220.95
- P/E Ratio
- HL $47.16
- ACLX N/A
- Revenue Growth
- HL 45.62
- ACLX N/A
- 52 Week Low
- HL $4.46
- ACLX $47.86
- 52 Week High
- HL $16.10
- ACLX $100.34
- Technical
- Relative Strength Index (RSI)
- HL 60.69
- ACLX 57.21
- Support Level
- HL $14.42
- ACLX $85.00
- Resistance Level
- HL $16.10
- ACLX $91.68
- Average True Range (ATR)
- HL 0.90
- ACLX 4.14
- MACD
- HL 0.15
- ACLX -0.08
- Stochastic Oscillator
- HL 68.26
- ACLX 71.76
About HL Hecla Mining Company
Hecla Mining Co produces and explores silver, gold, zinc, and other metals. The operating business segments are Greens Creek, Lucky Friday, Keno Hill, and Casa Berardi. It generates maximum revenue from the Greens Creek segment. Geographically, It operates in Canada, the United States, and Mexico, and it derives a majority of its revenue from the United States.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.